{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:22:44Z","timestamp":1792650164946,"version":"4.5.0"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T00:00:00Z","timestamp":1453680000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s10096-016-2579-y","type":"journal-article","created":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T09:39:30Z","timestamp":1453714770000},"page":"535-543","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Manipulation of BCG vaccine: a double-edged sword"],"prefix":"10.1007","volume":"35","author":[{"given":"V. K.","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. S.","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,25]]},"reference":[{"key":"2579_CR1","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1126\/science.257.5073.1055","volume":"57","author":"BR Bloom","year":"1992","unstructured":"Bloom BR, Murray CJ (1992) Tuberculosis: commentary on a reemergent killer. Science 57:1055\u20131064","journal-title":"Science"},{"key":"2579_CR2","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/thx.38.11.806","volume":"38","author":"A Sakula","year":"1983","unstructured":"Sakula A (1983) BCG: who were Calmette and Gu\u00e9rin? Thorax 38:806\u2013812","journal-title":"Thorax"},{"key":"2579_CR3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1438-4221(00)80083-1","volume":"290","author":"R Brosch","year":"2000","unstructured":"Brosch R, Gordon SV, Pym A, Eiglmeier K, Garnier T, Cole ST (2000) Comparative genomics of the mycobacteria. Int J Med Microbiol 290:143\u2013152. doi: 10.1016\/S1438-4221(00)80083-1","journal-title":"Int J Med Microbiol"},{"key":"2579_CR4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/31159","volume":"393","author":"ST Cole","year":"1998","unstructured":"Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D et al (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537\u2013544. doi: 10.1038\/31159","journal-title":"Nature"},{"key":"2579_CR5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.7774\/cevr.2013.2.2.83","volume":"2","author":"SM Joung","year":"2013","unstructured":"Joung SM, Ryoo S (2013) BCG vaccine in Korea. Clin Exp Vaccine Res 2:83\u201391. doi: 10.7774\/cevr.2013.2.2.83","journal-title":"Clin Exp Vaccine Res"},{"key":"2579_CR6","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1126\/science.284.5419.1520","volume":"284","author":"MA Behr","year":"1999","unstructured":"Behr MA, Wilson MA, Gill WP, Salamon H, Schoolnik GK, Rane S et al (1999) Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284:1520\u20131523","journal-title":"Science"},{"key":"2579_CR7","first-page":"11","volume":"19","author":"SP Tripathy","year":"1983","unstructured":"Tripathy SP (1983) The case for B.C.G. Ann Natl Acad Med Sci 19:11\u201321","journal-title":"Ann Natl Acad Med Sci"},{"key":"2579_CR8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fimmu.2014.00152","volume":"5","author":"AC Costa da","year":"2014","unstructured":"da Costa AC, Nogueira SV, Kipnis A, Junqueira-Kipnis AP (2014) Recombinant BCG: innovations on an Old vaccine. Scope of BCG strains and strategies to improve long-lasting memory. Front Immunol 5:152. doi: 10.3389\/fimmu.2014.00152","journal-title":"Front Immunol"},{"key":"2579_CR9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","volume":"27","author":"AM Cooper","year":"2009","unstructured":"Cooper AM (2009) Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 27:393\u2013422. doi: 10.1146\/annurev.immunol.021908.132703","journal-title":"Annu Rev Immunol"},{"key":"2579_CR10","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1002\/eji.201142158","volume":"42","author":"JE Pearl","year":"2012","unstructured":"Pearl JE, Torrado E, Tighe M, Fountain JJ, Solache A, Strutt T et al (2012) Nitric oxide inhibits the accumulation of CD4+CD44hiTbet+CD69lo T cells in mycobacterial infection. Eur J Immunol 42:3267\u20133279. doi: 10.1002\/eji.201142158","journal-title":"Eur J Immunol"},{"key":"2579_CR11","first-page":"268","volume":"7","author":"C Geldmacher","year":"2012","unstructured":"Geldmacher C, Zumla A, Hoelscher M (2012) Interaction between HIV and Mycobacterium tuberculosis: HIV-1-induced CD4 T-cell depletion and the development of active tuberculosis. Curr Opin HIV AIDS 7:268\u2013275. doi: 10.1097\/COH.0b013e3283524e32","journal-title":"Curr Opin HIV AIDS"},{"key":"2579_CR12","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev-immunol-032712-095939","volume":"31","author":"A O\u2019Garra","year":"2013","unstructured":"O\u2019Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, Berry MPR (2013) The immune response in tuberculosis. Annu Rev Immunol 31:475\u2013527. doi: 10.1146\/annurev-immunol-032712-095939","journal-title":"Annu Rev Immunol"},{"key":"2579_CR13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/imr.12259","volume":"264","author":"RT Robinson","year":"2015","unstructured":"Robinson RT, Orme IM, Cooper AM (2015) The onset of adaptive immunity in the mouse model of tuberculosis and the factors that compromise its expression. Immunol Rev 264:46\u201359. doi: 10.1111\/imr.12259","journal-title":"Immunol Rev"},{"key":"2579_CR14","first-page":"71","volume":"215","author":"LS Schlesinger","year":"1996","unstructured":"Schlesinger LS (1996) Entry of Mycobacterium tuberculosis into mononuclear phagocytes. Curr Top Microbiol Immunol 215:71\u201396","journal-title":"Curr Top Microbiol Immunol"},{"key":"2579_CR15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1378\/chest.09-0903","volume":"137","author":"S-Y Eum","year":"2010","unstructured":"Eum S-Y, Kong J-H, Hong M-S, Lee Y-J, Kim J-H, Hwang S-H et al (2010) Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. Chest 137:122\u2013128. doi: 10.1378\/chest.09-0903","journal-title":"Chest"},{"key":"2579_CR16","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.4049\/jimmunol.179.4.2509","volume":"179","author":"AJ Wolf","year":"2007","unstructured":"Wolf AJ, Linas B, Trevejo-Nu\u00f1ez GJ, Kincaid E, Tamura T, Takatsu K et al (2007) Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J Immunol 179:2509\u20132519","journal-title":"J Immunol"},{"key":"2579_CR17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10875-007-9084-0","volume":"27","author":"K Bhatt","year":"2007","unstructured":"Bhatt K, Salgame P (2007) Host innate immune response to Mycobacterium tuberculosis. J Clin Immunol 27:347\u2013362. doi: 10.1007\/s10875-007-9084-0","journal-title":"J Clin Immunol"},{"key":"2579_CR18","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.4049\/jimmunol.176.6.3707","volume":"176","author":"M Chen","year":"2006","unstructured":"Chen M, Gan H, Remold HG (2006) A mechanism of virulence: virulent Mycobacterium tuberculosis strain H37Rv, but not attenuated H37Ra, causes significant mitochondrial inner membrane disruption in macrophages leading to necrosis. J Immunol 176:3707\u20133716","journal-title":"J Immunol"},{"key":"2579_CR19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","volume":"19","author":"JL Flynn","year":"2001","unstructured":"Flynn JL, Chan J (2001) Immunology of tuberculosis. Annu Rev Immunol 19:93\u2013129. doi: 10.1146\/annurev.immunol.19.1.93","journal-title":"Annu Rev Immunol"},{"key":"2579_CR20","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1084\/jem.20080767","volume":"205","author":"M Chen","year":"2008","unstructured":"Chen M, Divangahi M, Gan H, Shin DSJ, Hong S, Lee DM et al (2008) Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. J Exp Med 205:2791\u20132801. doi: 10.1084\/jem.20080767","journal-title":"J Exp Med"},{"key":"2579_CR21","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/ni.1758","volume":"10","author":"M Divangahi","year":"2009","unstructured":"Divangahi M, Chen M, Gan H, Desjardins D, Hickman TT, Lee DM et al (2009) Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat Immunol 10:899\u2013906. doi: 10.1038\/ni.1758","journal-title":"Nat Immunol"},{"key":"2579_CR22","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrmicro2387","volume":"8","author":"SM Behar","year":"2010","unstructured":"Behar SM, Divangahi M, Remold HG (2010) Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy? Nat Rev Microbiol 8:668\u2013674. doi: 10.1038\/nrmicro2387","journal-title":"Nat Rev Microbiol"},{"key":"2579_CR23","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1172\/JCI45666","volume":"121","author":"P Elkington","year":"2011","unstructured":"Elkington P, Shiomi T, Breen R, Nuttall RK, Ugarte-Gil CA, Walker NF et al (2011) MMP-1 drives immunopathology in human tuberculosis and transgenic mice. J Clin Invest 121:1827\u20131833. doi: 10.1172\/JCI45666","journal-title":"J Clin Invest"},{"key":"2579_CR24","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1164\/rccm.200505-753OC","volume":"172","author":"PTG Elkington","year":"2005","unstructured":"Elkington PTG, Nuttall RK, Boyle JJ, O\u2019Kane CM, Horncastle DE, Edwards DR et al (2005) Mycobacterium tuberculosis, but not vaccine BCG, specifically upregulates matrix metalloproteinase-1. Am J Respir Crit Care Med 172:1596\u20131604. doi: 10.1164\/rccm.200505-753OC","journal-title":"Am J Respir Crit Care Med"},{"key":"2579_CR25","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1183\/09031936.00015411","volume":"38","author":"PT Elkington","year":"2011","unstructured":"Elkington PT, Ugarte-Gil CA, Friedland JS (2011) Matrix metalloproteinases in tuberculosis. Eur Respir J 38:456\u2013464. doi: 10.1183\/09031936.00015411","journal-title":"Eur Respir J"},{"key":"2579_CR26","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/1074-7613(95)90001-2","volume":"2","author":"JL Flynn","year":"1995","unstructured":"Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ et al (1995) Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561\u2013572","journal-title":"Immunity"},{"key":"2579_CR27","doi-asserted-by":"crossref","first-page":"7110","DOI":"10.4049\/jimmunol.1100001","volume":"186","author":"R Blomgran","year":"2011","unstructured":"Blomgran R, Ernst JD (2011) Lung neutrophils facilitate activation of naive antigen-specific CD4+ T cells during Mycobacterium tuberculosis infection. J Immunol 186:7110\u20137119. doi: 10.4049\/jimmunol.1100001","journal-title":"J Immunol"},{"key":"2579_CR28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.12251","volume":"264","author":"L Majlessi","year":"2015","unstructured":"Majlessi L, Prados-Rosales R, Casadevall A, Brosch R (2015) Release of mycobacterial antigens. Immunol Rev 264:25\u201345. doi: 10.1111\/imr.12251","journal-title":"Immunol Rev"},{"key":"2579_CR29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2958.2009.06784.x","volume":"73","author":"D Bottai","year":"2009","unstructured":"Bottai D, Brosch R (2009) Mycobacterial PE, PPE and ESX clusters: novel insights into the secretion of these most unusual protein families. Mol Microbiol 73:325\u2013328. doi: 10.1111\/j.1365-2958.2009.06784.x","journal-title":"Mol Microbiol"},{"key":"2579_CR30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-2148-6-95","volume":"6","author":"NC Gey van Pittius","year":"2006","unstructured":"Gey van Pittius NC, Sampson SL, Lee H, Kim Y, van Helden PD, Warren RM (2006) Evolution and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with the duplication of the ESAT-6 (esx) gene cluster regions. BMC Evol Biol 6:95. doi: 10.1186\/1471-2148-6-95","journal-title":"BMC Evol Biol"},{"key":"2579_CR31","doi-asserted-by":"crossref","first-page":"19024","DOI":"10.1074\/jbc.M110.204966","volume":"286","author":"MH Daleke","year":"2011","unstructured":"Daleke MH, Cascioferro A, de Punder K, Ummels R, Abdallah AM, van der Wel N et al (2011) Conserved Pro-Glu (PE) and Pro-Pro-Glu (PPE) protein domains target LipY lipases of pathogenic mycobacteria to the cell surface via the ESX-5 pathway. J Biol Chem 286:19024\u201319034. doi: 10.1074\/jbc.M110.204966","journal-title":"J Biol Chem"},{"key":"2579_CR32","first-page":"56","volume":"110","author":"[No authors listed]","year":"1999","unstructured":"[No authors listed] (1999) Fifteen year follow up of trial of BCG vaccines in south India for tuberculosis prevention. Tuberculosis research centre (ICMR), Chennai. Indian J Med Res 110:56\u201369","journal-title":"Indian J Med Res"},{"key":"2579_CR33","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","volume":"271","author":"GA Colditz","year":"1994","unstructured":"Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV et al (1994) Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271:698\u2013702","journal-title":"JAMA"},{"key":"2579_CR34","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1086\/322042","volume":"184","author":"GF Black","year":"2001","unstructured":"Black GF, Dockrell HM, Crampin AC, Floyd S, Weir RE, Bliss L et al (2001) Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi. J Infect Dis 184:322\u2013329. doi: 10.1086\/322042","journal-title":"J Infect Dis"},{"key":"2579_CR35","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","volume":"346","author":"PE Fine","year":"1995","unstructured":"Fine PE (1995) Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346:1339\u20131345","journal-title":"Lancet"},{"key":"2579_CR36","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1016\/j.vaccine.2009.08.044","volume":"27","author":"RG Bastos","year":"2009","unstructured":"Bastos RG, Borsuk S, Seixas FK, Dellagostin OA (2009) Recombinant Mycobacterium bovis BCG. Vaccine 27:6495\u20136503. doi: 10.1016\/j.vaccine.2009.08.044","journal-title":"Vaccine"},{"key":"2579_CR37","doi-asserted-by":"crossref","first-page":"13853","DOI":"10.1073\/pnas.250480397","volume":"97","author":"MA Horwitz","year":"2000","unstructured":"Horwitz MA, Harth G, Dillon BJ, Maslesa-Galic\u2019 S (2000) Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc Natl Acad Sci U S A 97:13853\u201313858. doi: 10.1073\/pnas.250480397","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2579_CR38","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1046\/j.1365-2249.2000.01100.x","volume":"119","author":"A Wangoo","year":"2000","unstructured":"Wangoo A, Brown IN, Marshall BG, Cook HT, Young DB, Shaw RJ (2000) Bacille Calmette-Gu\u00e9rin (BCG)-associated inflammation and fibrosis: modulation by recombinant BCG expressing interferon-gamma (IFN-gamma). Clin Exp Immunol 119:92\u201398","journal-title":"Clin Exp Immunol"},{"key":"2579_CR39","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1073\/pnas.93.2.934","volume":"93","author":"PJ Murray","year":"1996","unstructured":"Murray PJ, Aldovini A, Young RA (1996) Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Gu\u00e9rin strains that secrete cytokines. Proc Natl Acad Sci U S A 93:934\u2013939","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2579_CR40","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1016\/j.vaccine.2011.04.086","volume":"29","author":"VK Singh","year":"2011","unstructured":"Singh VK, Srivastava V, Singh V, Rastogi N, Roy R, Shaw AK et al (2011) Overexpression of Rv3097c in Mycobacterium bovis BCG abolished the efficacy of BCG vaccine to protect against Mycobacterium tuberculosis infection in mice. Vaccine 29:4754\u20134760. doi: 10.1016\/j.vaccine.2011.04.086","journal-title":"Vaccine"},{"key":"2579_CR41","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1473-3099(02)00182-2","volume":"2","author":"MA Behr","year":"2002","unstructured":"Behr MA (2002) BCG\u2014different strains, different vaccines? Lancet Infect Dis 2:86\u201392","journal-title":"Lancet Infect Dis"},{"key":"2579_CR42","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/38151","volume":"389","author":"MA Behr","year":"1997","unstructured":"Behr MA, Small PM (1997) Has BCG attenuated to impotence? Nature 389:133\u2013134. doi: 10.1038\/38151","journal-title":"Nature"},{"key":"2579_CR43","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1365-2958.1999.01383.x","volume":"32","author":"SV Gordon","year":"1999","unstructured":"Gordon SV, Brosch R, Billault A, Garnier T, Eiglmeier K, Cole ST (1999) Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays. Mol Microbiol 32:643\u2013655","journal-title":"Mol Microbiol"},{"key":"2579_CR44","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1046\/j.1365-2958.1999.01549.x","volume":"33","author":"PR Jungblut","year":"1999","unstructured":"Jungblut PR, Schaible UE, Mollenkopf HJ, Zimny-Arndt U, Raupach B, Mattow J et al (1999) Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains: towards functional genomics of microbial pathogens. Mol Microbiol 33:1103\u20131117","journal-title":"Mol Microbiol"},{"key":"2579_CR45","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1128\/jb.178.5.1274-1282.1996","volume":"178","author":"GG Mahairas","year":"1996","unstructured":"Mahairas GG, Sabo PJ, Hickey MJ, Singh DC, Stover CK (1996) Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol 178:1274\u20131282","journal-title":"J Bacteriol"},{"key":"2579_CR46","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nm859","volume":"9","author":"AS Pym","year":"2003","unstructured":"Pym AS, Brodin P, Majlessi L, Brosch R, Demangel C, Williams A et al (2003) Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat Med 9:533\u2013539. doi: 10.1038\/nm859","journal-title":"Nat Med"},{"key":"2579_CR47","first-page":"1068","volume":"10","author":"SHE Kaufmann","year":"2006","unstructured":"Kaufmann SHE, Baumann S, Nasser Eddine A (2006) Exploiting immunology and molecular genetics for rational vaccine design against tuberculosis. Int J Tuberc Lung Dis 10:1068\u20131079","journal-title":"Int J Tuberc Lung Dis"},{"key":"2579_CR48","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1128\/IAI.69.5.2773-2778.2001","volume":"69","author":"A Weinrich Olsen","year":"2001","unstructured":"Weinrich Olsen A, van Pinxteren LA, Meng Okkels L, Birk Rasmussen P, Andersen P (2001) Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6. Infect Immun 69:2773\u20132778. doi: 10.1128\/IAI.69.5.2773-2778.2001","journal-title":"Infect Immun"},{"key":"2579_CR49","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","volume":"171","author":"NP Goonetilleke","year":"2003","unstructured":"Goonetilleke NP, McShane H, Hannan CM, Anderson RJ, Brookes RH, Hill AVS (2003) Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Gu\u00e9rin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara. J Immunol 171:1602\u20131609","journal-title":"J Immunol"},{"key":"2579_CR50","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0264-410X(02)00447-4","volume":"21","author":"EM Agger","year":"2002","unstructured":"Agger EM, Andersen P (2002) A novel TB vaccine; towards a strategy based on our understanding of BCG failure. Vaccine 21:7\u201314","journal-title":"Vaccine"},{"key":"2579_CR51","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","volume":"115","author":"L Grode","year":"2005","unstructured":"Grode L, Seiler P, Baumann S, Hess J, Brinkmann V, Nasser Eddine A et al (2005) Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Gu\u00e9rin mutants that secrete listeriolysin. J Clin Invest 115:2472\u20132479. doi: 10.1172\/JCI24617","journal-title":"J Clin Invest"},{"key":"2579_CR52","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/infdis\/jir592","volume":"204","author":"C Desel","year":"2011","unstructured":"Desel C, Dorhoi A, Bandermann S, Grode L, Eisele B, Kaufmann SHE (2011) Recombinant BCG \u0394ureC hly+ induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responses. J Infect Dis 204:1573\u20131584. doi: 10.1093\/infdis\/jir592","journal-title":"J Infect Dis"},{"key":"2579_CR53","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1126\/science.276.5319.1684","volume":"276","author":"S Stenger","year":"1997","unstructured":"Stenger S, Mazzaccaro RJ, Uyemura K, Cho S, Barnes PF, Rosat JP et al (1997) Differential effects of cytolytic T cell subsets on intracellular infection. Science 276:1684\u20131687","journal-title":"Science"},{"key":"2579_CR54","doi-asserted-by":"crossref","first-page":"12210","DOI":"10.1073\/pnas.210391497","volume":"97","author":"S Cho","year":"2000","unstructured":"Cho S, Mehra V, Thoma-Uszynski S, Stenger S, Serbina N, Mazzaccaro RJ et al (2000) Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis. Proc Natl Acad Sci U S A 97:12210\u201312215. doi: 10.1073\/pnas.210391497","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2579_CR55","doi-asserted-by":"crossref","first-page":"12013","DOI":"10.1073\/pnas.89.24.12013","volume":"89","author":"JL Flynn","year":"1992","unstructured":"Flynn JL, Goldstein MM, Triebold KJ, Koller B, Bloom BR (1992) Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A 89:12013\u201312017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2579_CR56","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.0818-9641.2002.01143.x","volume":"81","author":"WJ Britton","year":"2003","unstructured":"Britton WJ, Palendira U (2003) Improving vaccines against tuberculosis. Immunol Cell Biol 81:34\u201345. doi: 10.1046\/j.0818-9641.2002.01143.x","journal-title":"Immunol Cell Biol"},{"issue":"Suppl 2","key":"2579_CR57","doi-asserted-by":"crossref","first-page":"S353","DOI":"10.1093\/clinids\/11.Supplement_2.S353","volume":"11","author":"PE Fine","year":"1989","unstructured":"Fine PE (1989) The BCG story: lessons from the past and implications for the future. Rev Infect Dis 11(Suppl 2):S353\u2013S359","journal-title":"Rev Infect Dis"},{"key":"2579_CR58","first-page":"553","volume":"94","author":"CE Palmer","year":"1966","unstructured":"Palmer CE, Long MW (1966) Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis. Am Rev Respir Dis 94:553\u2013568","journal-title":"Am Rev Respir Dis"},{"key":"2579_CR59","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0041-3879(81)90038-6","volume":"62","author":"GA Rook","year":"1981","unstructured":"Rook GA, Bahr GM, Stanford JL (1981) The effect of two distinct forms of cell-mediated response to mycobacteria on the protective efficacy of BCG. Tubercle 62:63\u201368","journal-title":"Tubercle"},{"key":"2579_CR60","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1128\/IAI.65.8.3317-3327.1997","volume":"65","author":"R Hernandez-Pando","year":"1997","unstructured":"Hernandez-Pando R, Pav\u00f6n L, Arriaga K, Orozco H, Madrid-Marina V, Rook G (1997) Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection. Infect Immun 65:3317\u20133327","journal-title":"Infect Immun"},{"key":"2579_CR61","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1086\/315200","volume":"181","author":"GT Seah","year":"2000","unstructured":"Seah GT, Scott GM, Rook GA (2000) Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J Infect Dis 181:385\u2013389. doi: 10.1086\/315200","journal-title":"J Infect Dis"},{"key":"2579_CR62","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1046\/j.1365-2249.2001.01428.x","volume":"123","author":"Y Luo","year":"2001","unstructured":"Luo Y, Chen X, Han R, O\u2019Donnell MA (2001) Recombinant bacille Calmette-Gu\u00e9rin (BCG) expressing human interferon-alpha 2B demonstrates enhanced immunogenicity. Clin Exp Immunol 123:264\u2013270","journal-title":"Clin Exp Immunol"},{"key":"2579_CR63","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.4049\/jimmunol.157.8.3527","volume":"157","author":"L Brandt","year":"1996","unstructured":"Brandt L, Oettinger T, Holm A, Andersen AB, Andersen P (1996) Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis. J Immunol 157:3527\u20133533","journal-title":"J Immunol"},{"key":"2579_CR64","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.4049\/jimmunol.154.7.3359","volume":"154","author":"P Andersen","year":"1995","unstructured":"Andersen P, Andersen AB, S\u00f8rensen AL, Nagai S (1995) Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J Immunol 154:3359\u20133372","journal-title":"J Immunol"},{"key":"2579_CR65","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1086\/318081","volume":"183","author":"A Lalvani","year":"2001","unstructured":"Lalvani A, Nagvenkar P, Udwadia Z, Pathan AA, Wilkinson KA, Shastri JS et al (2001) Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis 183:469\u2013477. doi: 10.1086\/318081","journal-title":"J Infect Dis"},{"key":"2579_CR66","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1086\/314640","volume":"179","author":"P Ravn","year":"1999","unstructured":"Ravn P, Demissie A, Eguale T, Wondwosson H, Lein D, Amoudy HA et al (1999) Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. J Infect Dis 179:637\u2013645. doi: 10.1086\/314640","journal-title":"J Infect Dis"},{"key":"2579_CR67","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1128\/IAI.67.4.1702-1707.1999","volume":"67","author":"AT Kamath","year":"1999","unstructured":"Kamath AT, Feng CG, Macdonald M, Briscoe H, Britton WJ (1999) Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. Infect Immun 67:1702\u20131707","journal-title":"Infect Immun"},{"key":"2579_CR68","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1128\/IAI.67.9.4780-4786.1999","volume":"67","author":"Z Li","year":"1999","unstructured":"Li Z, Howard A, Kelley C, Delogu G, Collins F, Morris S (1999) Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences. Infect Immun 67:4780\u20134786","journal-title":"Infect Immun"},{"key":"2579_CR69","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/IAI.68.2.791-795.2000","volume":"68","author":"L Brandt","year":"2000","unstructured":"Brandt L, Elhay M, Rosenkrands I, Lindblad EB, Andersen P (2000) ESAT-6 subunit vaccination against Mycobacterium tuberculosis. Infect Immun 68:791\u2013795","journal-title":"Infect Immun"},{"key":"2579_CR70","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/1521-4141(200006)30:6<1724::AID-IMMU1724>3.0.CO;2-A","volume":"30","author":"AW Olsen","year":"2000","unstructured":"Olsen AW, Hansen PR, Holm A, Andersen P (2000) Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. Eur J Immunol 30:1724\u20131732. doi: 10.1002\/1521-4141(200006)30:6<1724::AID-IMMU1724>3.0.CO;2-A","journal-title":"Eur J Immunol"},{"key":"2579_CR71","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0140-6736(98)07422-4","volume":"353","author":"AB Alexandroff","year":"1999","unstructured":"Alexandroff AB, Jackson AM, O\u2019Donnell MA, James K (1999) BCG immunotherapy of bladder cancer: 20 years on. Lancet 353:1689\u20131694. doi: 10.1016\/S0140-6736(98)07422-4","journal-title":"Lancet"},{"key":"2579_CR72","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1128\/IAI.62.6.2508-2514.1994","volume":"62","author":"MA O\u2019Donnell","year":"1994","unstructured":"O\u2019Donnell MA, Aldovini A, Duda RB, Yang H, Szilvasi A, Young RA et al (1994) Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes. Infect Immun 62:2508\u20132514","journal-title":"Infect Immun"},{"key":"2579_CR73","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/intimm\/dxf050","volume":"14","author":"SL Young","year":"2002","unstructured":"Young SL, O\u2019Donnell MA, Buchan GS (2002) IL-2-secreting recombinant bacillus Calmette Guerin can overcome a Type 2 immune response and corticosteroid-induced immunosuppression to elicit a Type 1 immune response. Int Immunol 14:793\u2013800","journal-title":"Int Immunol"},{"key":"2579_CR74","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1128\/IAI.70.12.6549-6557.2002","volume":"70","author":"F Biet","year":"2002","unstructured":"Biet F, Kremer L, Wolowczuk I, Delacre M, Locht C (2002) Mycobacterium bovis BCG producing interleukin-18 increases antigen-specific gamma interferon production in mice. Infect Immun 70:6549\u20136557","journal-title":"Infect Immun"},{"key":"2579_CR75","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1086\/592450","volume":"198","author":"DF Hoft","year":"2008","unstructured":"Hoft DF, Blazevic A, Abate G, Hanekom WA, Kaplan G, Soler JH et al (2008) A new recombinant bacille Calmette-Gu\u00e9rin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers. J Infect Dis 198:1491\u20131501. doi: 10.1086\/592450","journal-title":"J Infect Dis"},{"key":"2579_CR76","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00430-002-0170-x","volume":"193","author":"N Dhar","year":"2004","unstructured":"Dhar N, Rao V, Tyagi AK (2004) Immunogenicity of recombinant BCG vaccine strains overexpressing components of the antigen 85 complex of Mycobacterium tuberculosis. Med Microbiol Immunol 193:19\u201325. doi: 10.1007\/s00430-002-0170-x","journal-title":"Med Microbiol Immunol"},{"key":"2579_CR77","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.tube.2007.06.002","volume":"87","author":"I Sugawara","year":"2007","unstructured":"Sugawara I, Li Z, Sun L, Udagawa T, Taniyama T (2007) Recombinant BCG Tokyo (Ag85A) protects cynomolgus monkeys (Macaca fascicularis) infected with H37Rv Mycobacterium tuberculosis. Tuberculosis (Edinb) 87:518\u2013525. doi: 10.1016\/j.tube.2007.06.002","journal-title":"Tuberculosis (Edinb)"},{"key":"2579_CR78","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.vaccine.2008.10.034","volume":"27","author":"E Badell","year":"2009","unstructured":"Badell E, Nicolle F, Clark S, Majlessi L, Boudou F, Martino A et al (2009) Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells. Vaccine 27:28\u201337. doi: 10.1016\/j.vaccine.2008.10.034","journal-title":"Vaccine"},{"key":"2579_CR79","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-3083.2007.02048.x","volume":"67","author":"YQ Qie","year":"2008","unstructured":"Qie YQ, Wang JL, Zhu BD, Xu Y, Wang QZ, Chen JZ et al (2008) Evaluation of a new recombinant BCG which contains mycobacterial antigen ag85B-mpt64(190-198)-mtb8.4 in C57\/BL6 mice. Scand J Immunol 67:133\u2013139. doi: 10.1111\/j.1365-3083.2007.02048.x","journal-title":"Scand J Immunol"},{"key":"2579_CR80","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1086\/586902","volume":"197","author":"C Tang","year":"2008","unstructured":"Tang C, Yamada H, Shibata K, Maeda N, Yoshida S, Wajjwalku W et al (2008) Efficacy of recombinant bacille Calmette-Gu\u00e9rin vaccine secreting interleukin-15\/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis. J Infect Dis 197:1263\u20131274. doi: 10.1086\/586902","journal-title":"J Infect Dis"},{"key":"2579_CR81","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-0463.2011.02815.x","volume":"120","author":"C-W Lin","year":"2012","unstructured":"Lin C-W, Su I-J, Chang J-R, Chen Y-Y, Lu J-J, Dou H-Y (2012) Recombinant BCG coexpressing Ag85B, CFP10, and interleukin-12 induces multifunctional Th1 and memory T cells in mice. APMIS 120:72\u201382. doi: 10.1111\/j.1600-0463.2011.02815.x","journal-title":"APMIS"},{"key":"2579_CR82","author":"Y-Y Chen","year":"2014","unstructured":"Chen Y-Y, Lin C-W, Huang W-F, Chang J-R, Su I-J, Hsu C-H et al (2014) Recombinant bacille Calmette-Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis. J Microbiol Immunol Infect. doi: 10.1016\/j.jmii.2014.11.019","journal-title":"J Microbiol Immunol Infect"},{"key":"2579_CR83","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/2051013615593891","volume":"3","author":"MJ Ahsan","year":"2015","unstructured":"Ahsan MJ (2015) Recent advances in the development of vaccines for tuberculosis. Ther Adv Vaccines 3:66\u201375. doi: 10.1177\/2051013615593891","journal-title":"Ther Adv Vaccines"},{"key":"2579_CR84","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.vaccine.2012.02.018","volume":"30","author":"WR Waters","year":"2012","unstructured":"Waters WR, Palmer MV, Buddle BM, Vordermeier HM (2012) Bovine tuberculosis vaccine research: historical perspectives and recent advances. Vaccine 30:2611\u20132622. doi: 10.1016\/j.vaccine.2012.02.018","journal-title":"Vaccine"},{"key":"2579_CR85","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.vetmic.2011.02.021","volume":"151","author":"BM Buddle","year":"2011","unstructured":"Buddle BM, Wedlock DN, Denis M, Vordermeier HM, Hewinson RG (2011) Update on vaccination of cattle and wildlife populations against tuberculosis. Vet Microbiol 151:14\u201322. doi: 10.1016\/j.vetmic.2011.02.021","journal-title":"Vet Microbiol"},{"key":"2579_CR86","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/dna.2008.0790","volume":"28","author":"X-D Hu","year":"2009","unstructured":"Hu X-D, Yu D-H, Chen S-T, Li S-X, Cai H (2009) A combined DNA vaccine provides protective immunity against Mycobacterium bovis and Brucella abortus in cattle. DNA Cell Biol 28:191\u2013199. doi: 10.1089\/dna.2008.0790","journal-title":"DNA Cell Biol"},{"key":"2579_CR87","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1128\/IAI.00287-09","volume":"77","author":"HM Vordermeier","year":"2009","unstructured":"Vordermeier HM, Villarreal-Ramos B, Cockle PJ, McAulay M, Rhodes SG, Thacker T et al (2009) Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis. Infect Immun 77:3364\u20133373. doi: 10.1128\/IAI.00287-09","journal-title":"Infect Immun"},{"key":"2579_CR88","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1128\/CVI.00034-08","volume":"15","author":"DN Wedlock","year":"2008","unstructured":"Wedlock DN, Denis M, Painter GF, Ainge GD, Vordermeier HM, Hewinson RG et al (2008) Enhanced protection against bovine tuberculosis after coadministration of Mycobacterium bovis BCG with a Mycobacterial protein vaccine-adjuvant combination but not after coadministration of adjuvant alone. Clin Vaccine Immunol 15:765\u2013772. doi: 10.1128\/CVI.00034-08","journal-title":"Clin Vaccine Immunol"},{"key":"2579_CR89","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1128\/IAI.73.6.3540-3546.2005","volume":"73","author":"DN Wedlock","year":"2005","unstructured":"Wedlock DN, Denis M, Skinner MA, Koach J, de Lisle GW, Vordermeier HM et al (2005) Vaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to those induced by vaccination with BCG alone. Infect Immun 73:3540\u20133546. doi: 10.1128\/IAI.73.6.3540-3546.2005","journal-title":"Infect Immun"},{"key":"2579_CR90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051396","volume":"7","author":"C Rizzi","year":"2012","unstructured":"Rizzi C, Bianco MV, Blanco FC, Soria M, Gravisaco MJ, Montenegro V et al (2012) Vaccination with a BCG strain overexpressing Ag85B protects cattle against Mycobacterium bovis challenge. PLoS One 7, e51396. doi: 10.1371\/journal.pone.0051396","journal-title":"PLoS One"},{"key":"2579_CR91","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.vaccine.2005.10.002","volume":"24","author":"MA Horwitz","year":"2006","unstructured":"Horwitz MA, Harth G, Dillon BJ, Maslesa-Gali\u0107 S (2006) A novel live recombinant mycobacterial vaccine against bovine tuberculosis more potent than BCG. Vaccine 24:1593\u20131600. doi: 10.1016\/j.vaccine.2005.10.002","journal-title":"Vaccine"},{"key":"2579_CR92","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.tube.2013.02.004","volume":"93","author":"FC Blanco","year":"2013","unstructured":"Blanco FC, Bianco MV, Garbaccio S, Meikle V, Gravisaco MJ, Montenegro V et al (2013) Mycobacterium bovis \u0394mce2 double deletion mutant protects cattle against challenge with virulent M. bovis. Tuberculosis (Edinb) 93:363\u2013372. doi: 10.1016\/j.tube.2013.02.004","journal-title":"Tuberculosis (Edinb)"},{"key":"2579_CR93","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.vaccine.2013.12.055","volume":"32","author":"B Khatri","year":"2014","unstructured":"Khatri B, Whelan A, Clifford D, Petrera A, Sander P, Vordermeier HM (2014) BCG \u0394zmp1 vaccine induces enhanced antigen specific immune responses in cattle. Vaccine 32:779\u2013784. doi: 10.1016\/j.vaccine.2013.12.055","journal-title":"Vaccine"},{"key":"2579_CR94","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tube.2015.01.001","volume":"95","author":"E Garc\u00eda","year":"2015","unstructured":"Garc\u00eda E, Bianco MV, Gravisaco MJ, Rocha RV, Blanco FC, Bigi F (2015) Evaluation of Mycobacterium bovis double knockout mce2-phoP as candidate vaccine against bovine tuberculosis. Tuberculosis (Edinb) 95:186\u2013189. doi: 10.1016\/j.tube.2015.01.001","journal-title":"Tuberculosis (Edinb)"},{"key":"2579_CR95","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1098\/rspb.2009.0414","volume":"276","author":"DM Tompkins","year":"2009","unstructured":"Tompkins DM, Ramsey DSL, Cross ML, Aldwell FE, de Lisle GW, Buddle BM (2009) Oral vaccination reduces the incidence of tuberculosis in free-living brushtail possums. Proc Biol Sci 276:2987\u20132995. doi: 10.1098\/rspb.2009.0414","journal-title":"Proc Biol Sci"},{"key":"2579_CR96","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.tvjl.2014.02.031","volume":"200","author":"D Murphy","year":"2014","unstructured":"Murphy D, Costello E, Aldwell FE, Lesellier S, Chambers MA, Fitzsimons T et al (2014) Oral vaccination of badgers (Meles meles) against tuberculosis: comparison of the protection generated by BCG vaccine strains Pasteur and Danish. Vet J 200:362\u2013367. doi: 10.1016\/j.tvjl.2014.02.031","journal-title":"Vet J"},{"key":"2579_CR97","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1054\/tuld.2000.0252","volume":"80","author":"VV Yeremeev","year":"2000","unstructured":"Yeremeev VV, Stewart GR, Neyrolles O, Skrabal K, Avdienko VG, Apt AS et al (2000) Deletion of the 19kDa antigen does not alter the protective efficacy of BCG. Tuber Lung Dis 80:243\u2013247. doi: 10.1054\/tuld.2000.0252","journal-title":"Tuber Lung Dis"},{"key":"2579_CR98","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-3083.2005.01569.x","volume":"61","author":"V Rao","year":"2005","unstructured":"Rao V, Dhar N, Shakila H, Singh R, Khera A, Jain R et al (2005) Increased expression of Mycobacterium tuberculosis 19 kDa lipoprotein obliterates the protective efficacy of BCG by polarizing host immune responses to the Th2 subtype. Scand J Immunol 61:410\u2013417. doi: 10.1111\/j.1365-3083.2005.01569.x","journal-title":"Scand J Immunol"},{"key":"2579_CR99","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrurol.2014.15","volume":"11","author":"G Redelman-Sidi","year":"2014","unstructured":"Redelman-Sidi G, Glickman MS, Bochner BH (2014) The mechanism of action of BCG therapy for bladder cancer\u2014a current perspective. Nat Rev Urol 11:153\u2013162. doi: 10.1038\/nrurol.2014.15","journal-title":"Nat Rev Urol"},{"key":"2579_CR100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1006\/expr.1999.4459","volume":"94","author":"JA Streit","year":"2000","unstructured":"Streit JA, Recker TJ, Donelson JE, Wilson ME (2000) BCG expressing LCR1 of Leishmania chagasi induces protective immunity in susceptible mice. Exp Parasitol 94:33\u201341. doi: 10.1006\/expr.1999.4459","journal-title":"Exp Parasitol"},{"key":"2579_CR101","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1128\/IAI.72.6.3336-3343.2004","volume":"72","author":"PB Varaldo","year":"2004","unstructured":"Varaldo PB, Leite LCC, Dias WO, Miyaji EN, Torres FIG, Gebara VC et al (2004) Recombinant Mycobacterium bovis BCG expressing the Sm14 antigen of Schistosoma mansoni protects mice from cercarial challenge. Infect Immun 72:3336\u20133343. doi: 10.1128\/IAI.72.6.3336-3343.2004","journal-title":"Infect Immun"},{"key":"2579_CR102","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.vaccine.2007.10.052","volume":"26","author":"FK Seixas","year":"2007","unstructured":"Seixas FK, da Silva EF, Hartwig DD, Cerqueira GM, Amaral M, Fagundes MQ et al (2007) Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge. Vaccine 26:88\u201395. doi: 10.1016\/j.vaccine.2007.10.052","journal-title":"Vaccine"},{"key":"2579_CR103","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/j.vaccine.2005.11.029","volume":"24","author":"VA Govan","year":"2006","unstructured":"Govan VA, Christensen ND, Berkower C, Jacobs WR Jr, Williamson A-L (2006) Immunisation with recombinant BCG expressing the cottontail rabbit papillomavirus (CRPV) L1 gene provides protection from CRPV challenge. Vaccine 24:2087\u20132093. doi: 10.1016\/j.vaccine.2005.11.029","journal-title":"Vaccine"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-016-2579-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-016-2579-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-016-2579-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T12:19:20Z","timestamp":1692188360000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-016-2579-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,25]]},"references-count":103,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["2579"],"URL":"https:\/\/doi.org\/10.1007\/s10096-016-2579-y","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,25]]}}}